
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
08/21/2025 | Q3 | $1.4B | -- | -- | $2.92 | -- |
05/21/2025 | Q2 | $1.2B | $1.3B | $2.09 | $1.62 | $0.47 |
02/26/2025 | Q1 | $1B | $1.1B | $1.11 | $0.90 | $0.21 |
11/20/2024 | Q4 | $1.2B | $1.3B | $2.37 | $2.31 | $0.06 |
08/21/2024 | Q3 | $1.2B | $1.2B | $2.32 | $2.26 | $0.06 |
05/22/2024 | Q2 | $1.1B | $1.1B | $2.12 | $1.51 | $0.61 |
02/28/2024 | Q1 | $970.1M | $952.5M | $0.79 | $0.97 | -$0.18 |
11/21/2023 | Q4 | -- | -- | $2.82 | $1.75 | $1.07 |
08/23/2023 | Q3 | -- | -- | $2.03 | $1.67 | $0.36 |
05/24/2023 | Q2 | -- | -- | $1.73 | $0.70 | $1.03 |
03/01/2023 | Q1 | -- | -- | $0.83 | $0.14 | $0.69 |
11/22/2022 | Q4 | -- | -- | $1.80 | $1.31 | $0.49 |
08/24/2022 | Q3 | -- | -- | $1.46 | $0.98 | $0.48 |
05/25/2022 | Q2 | -- | -- | $0.65 | $0.16 | $0.49 |
05/25/2022 | Q1 | -- | -- | -$0.00 | -- | -- |
03/02/2022 | Q1 | -- | -- | $0.03 | -$0.09 | $0.12 |
11/23/2021 | Q4 | -- | -- | $0.94 | $0.69 | $0.25 |
09/01/2021 | Q3 | -- | -- | $0.59 | $0.75 | -$0.16 |
05/25/2021 | Q2 | -- | -- | $0.03 | $0.08 | -$0.05 |
03/03/2021 | Q1 | -- | -- | -$0.13 | $0.07 | -$0.20 |
11/24/2020 | Q4 | -- | -- | $1.05 | $1.05 | -- |
08/26/2020 | Q3 | -- | -- | $1.15 | $0.67 | $0.48 |
05/19/2020 | Q2 | -- | -- | -$1.03 | -$0.03 | -$1.00 |
02/26/2020 | Q1 | -- | -- | -$0.35 | -$0.04 | -$0.31 |
11/26/2019 | Q4 | -- | -- | $0.76 | $0.72 | $0.04 |
08/28/2019 | Q3 | -- | -- | $0.94 | $0.82 | $0.12 |
05/21/2019 | Q2 | -- | -- | $0.45 | $0.42 | $0.03 |
02/27/2019 | Q1 | -- | -- | -$0.38 | -- | -- |
11/20/2018 | Q4 | -- | -- | $0.87 | -- | -- |
08/13/2018 | Q3 | -- | -- | $0.94 | -- | -- |
05/22/2018 | Q2 | -- | -- | $0.53 | -- | -- |
02/28/2018 | Q1 | -- | -- | $0.12 | $0.10 | $0.02 |
11/21/2017 | Q4 | -- | -- | $0.90 | -- | -- |
08/30/2017 | Q3 | -- | -- | $1.38 | -- | -- |
05/24/2017 | Q2 | -- | -- | $1.22 | -- | -- |
03/01/2017 | Q1 | -- | -- | $0.74 | -- | -- |
11/21/2016 | Q4 | -- | -- | $1.59 | -- | -- |
08/23/2016 | Q3 | -- | -- | $1.54 | -- | -- |
05/24/2016 | Q2 | -- | -- | $1.00 | -- | -- |
02/24/2016 | Q1 | -- | -- | $0.46 | -- | -- |
11/24/2015 | Q4 | -- | -- | $0.91 | -- | -- |
08/26/2015 | Q3 | -- | -- | $0.97 | -- | -- |
Dycom Industries reported $1.3B worth of top line sales in its most recent quarter.
Dycom Industries announced earnings per share of $2.09 which represents a beat of analyst forecast a $1.62 per share.
Dycom Industries reported $247.5M that represents $8.46 per share over the last quarter.
Dycom Industries's earnings are forecast to grow from $7.92 per share to $8.09 per share next year representing an increase of 21.87%.
Dycom Industries's next earnings date is August 21, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.